期刊文献+

灌注化疗前后P_(53)、bcl-2和血管内皮生长因子在浸润性膀胱肿瘤中的表达 被引量:2

Expression of P_(53)bcl-2 and VEGF in patient with invasive bladder tumor before and after Intra-arterial chemotherapy
下载PDF
导出
摘要 目的探讨髂内动脉灌注化疗前后P53、bcl-2、血管内皮生长因子(VEGF)在浸润性膀胱肿瘤组织中表达的意义。方法采用免疫组化法对8例浸润性膀胱肿瘤患者动脉灌注化疗前后血清中的P53、bcl-2、VEGF进行检测。结果灌注前P53的表达率为50%(+~++),bcl-2的表达率为50%(+~+++),VEGF的表达率为50%(+~++);灌注后P53的表达率为50%(+~++),bcl-2为阴性,VEGF的表达率为50%(+)。结论灌注化疗能降低肿瘤标记物的表达,检测P53、bcl-2、VEGF对肿瘤治疗的有效性和预后判断有重要意义。 Objective To investigate the significance of expression of P53?bcl-2 and VEGF in patient with invasive bladder tumor before and after Intra-arterial chemotherapy. Methods 8 cases of bladder tumors were detected by immunohitochemistry technique on P53?bcl-2 and VEGF before and after Intra-arterial chemotherapy. Results Before Intra-arterial chemotherapy, the expression rate of P53, bcl-2 and VEGF were all 50%; after Intra-arterial chemotherapy, P53 was 50%, bcl-2 was negative and VEGF was 50%. Conclusions Intra-arterial chemotherapy can reduce the expression of tumor markers, it may play an important role in effective therapy of invasive bladder cancer and the evaluation of prognosis.
出处 《北京医学》 CAS 2005年第4期222-224,共3页 Beijing Medical Journal
关键词 膀胱肿瘤 肿瘤标记物 免疫组化 灌注化疗 Bladder tumor Tumor markers Immunohistochemistry Intra-arterial chemotherapy
  • 相关文献

参考文献5

  • 1叶敏,舒畅,马邦一,陈建华,张良.吡柔比星诱导膀胱癌细胞凋亡的实验研究及预防膀胱癌术后复发的效果[J].中华泌尿外科杂志,2002,23(1):16-18. 被引量:157
  • 2Rodriguez-Alonso A, Pita-Fernandez S, Gonzalez-Carrero J, et al.Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma. Cancer, 2002, 94:1677 - 1684.
  • 3Vollmer RT, Humphrey PA, Swanson PE, et al. Invasion of the bladder by transitional cell carcinoma:its relation to histologic grade and expression of P53, MIB-1, c-erb B-2, epidermal growth factor teceptor, and bcl-2. Cancer, 1998, 82:715 - 723.
  • 4Streeter EH, Harris AL. Angiogenesis in bladder cancer -prognostic marker and target for future therapy. Surg Oncol, 2002, 11: 85 -100
  • 5Furusawa S. Potential of pirarubicin in multidrug resistant cell by rifampicin. Biol Pharm Bull, 1997, 20:1303 - 1306.

二级参考文献3

共引文献156

同被引文献14

  • 1李道兵,罗旭,李春鸣,刘华庆,付逆.微血管密度和VEGF在膀胱癌中的表达及意义[J].华西医学,2006,21(2):237-238. 被引量:2
  • 2Luo D,Vermijlen D,Ahishali B,et al.MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cellmediated apoptosis and cytolysis,by blocking the perforin/granzyme pathway.Comparative Hepatology,2002,1:2-9.
  • 3Jemal A,Siegel R, Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,20{19, a(4) 4).
  • 4Zhong H,De Marzo AM,Laughner E,et al.Overexpression of hypoxia- inducible factor 1alpha in common human cancers and their metastases[J].Cancer Res,1999,59:5830-5835.
  • 5Bachtiary B, Schindl M, Potter R, et al.Overexepression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer [Jl.Clin Cancer Res,2003,9:2234-2240.
  • 6Bryan RT, Zeegers MP, James ND, et al.Biomarkers in bladder cancerJ].BJU Int, 2010,105(5):608-613.
  • 7LI TJ, Browne RaM, Matthews JB. Epithelial cell proliferation in odontogenickeratocysts: a comparative.imnmnocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions [J].J Oral Pathol Med, 1995, 24 (5):221-226.
  • 8Scott RJ, Hail PA, Haldane JS,et al.A comparison of immunohistoehemieal markers of cell proliferation with experimentally determined growth fi'action [J]J Pathol,1991,165(2) : 173-178.
  • 9Onozawa M, Miyanaga N, Hinotsu S, et al. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer[J].Jpn J Clin 0ncol.2012 ,Sep,42(9):825-30.
  • 10彭晓晖,祖雄兵.缺氧诱导因子-1α和血管内皮生长因子在膀胱癌中的表达及其与微血管密度的关系[J].中国现代医学杂志,2009,19(18):2787-2789. 被引量:4

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部